We continue to be excited about our collaboration with Canary Health, a leading digital therapeutics company that offers proven digital health self-management programs for people with chronic diseases. With the Canary Health’s well-established programs, we are able to offer healthcare organizations broader, deeper, and more holistic diabetes management solutions that improve clinical outcomes, while
I’d like to share a blog post authored by Sarah Knotts — a customer who recently switched over to the MiniMed™ 670G system. Sarah was initially skeptical of our hybrid closed-loop system but after trying it, she said the system “gave [her] peace of mind.” Like many living with Type 1 diabetes (T1D), managing
Hypoglycemia (low blood glucose) can be very dangerous and is one of the most frightening situations for people with diabetes – particularly during the night when an estimated 57% of people with type 1 diabetes experience a low at least once.[i] Not to mention it impacts their quality of life and takes time out
For more than 30 years, Medtronic Diabetes has been known as an insulin pump and sensor company. While we have made great progress in improving outcomes and care for people with diabetes, we believe we can make a greater impact. This means changing our strategy. We are exploring new models of care, including integrated
A couple months ago, I had a very interesting evening at a dinner in London with the Medtronic Board of Directors, members of the Executive Committee, senior leaders, and physicians from some of the most prestigious hospitals in the United Kingdom (UK), as well as members of the National Health Service. The dinner was
I am excited to announce Diabetes, Obesity and Metabolism, an international, peer-reviewed journal, recently published the results of the continuation phase of our OpT2mise study, which could redefine the standard of care and expand access to insulin pump therapy for the growing population of insulin-dependent people with type 2 diabetes with poor glucose control.